WPI 2233 (Tamoxifen 20 mg)
Pill imprint WPI 2233 has been identified as Tamoxifen citrate 20 mg.
Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant; breast cancer, male; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not subject to the Controlled Substances Act.
See also related documents.
- 20 mg
- Prescription only
Selective estrogen receptor modulators
pregelatinized corn starch
More about tamoxifen
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.